<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37999770</PMID><DateCompleted><Year>2024</Year><Month>01</Month><Day>08</Day></DateCompleted><DateRevised><Year>2024</Year><Month>04</Month><Day>05</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1432-1459</ISSN><JournalIssue CitedMedium="Internet"><Volume>271</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Journal of neurology</Title><ISOAbbreviation>J Neurol</ISOAbbreviation></Journal><ArticleTitle>Cerebrospinal fluid findings in patients with neurological manifestations in post-COVID-19 syndrome.</ArticleTitle><Pagination><StartPage>59</StartPage><EndPage>70</EndPage><MedlinePgn>59-70</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00415-023-12092-4</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Information on cerebrospinal fluid (CSF) findings in patients with neurological manifestations in post-COVID-19 syndrome is scarce.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Retrospective evaluation of 84 CSF samples in patients fulfilling post-COVID-19 criteria in two neurological post-COVID-19 outpatient clinics.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">In 68% of samples, all CSF parameters were normal. The most frequent pathological CSF finding was elevation of total protein (median total protein 33.3 mg/dl [total range 18.5-116.2]) in 20 of 83 (24%) samples. The second most prevalent pathological finding was a blood-CSF barrier dysfunction as measured by elevation of QAlb (median QAlb 4.65 [2.4-13.2]) in 11/84 (13%). Pleocytosis was found in only 5/84 (6%) samples and was mild in all of them. CSF-restricted oligoclonal bands were found in 5/83 (6%) samples. Anti-neuronal autoantibodies in CSF were negative in most cases, whilst 12/68 (18%) samples were positive for anti-myelin autoantibodies in serum. PCR for herpesviridae (HSV-1/-2, VZV, EBV, CMV, HHV6) showed, if at all, only weakly positive results in CSF or EDTA whole blood/plasma.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The majority of samples did not show any pathologies. The most frequent findings were elevation of total protein and blood-CSF barrier dysfunction with no signs of intrathecal inflammation. CSF analysis still keeps its value for exclusion of differential diagnoses.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Boesl</LastName><ForeName>Fabian</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0002-7345-7701</Identifier><AffiliationInfo><Affiliation>Charit&#xe9; - Universit&#xe4;tsmedizin Berlin, Corporate member of Freie Universit&#xe4;t Berlin and Humboldt-Universit&#xe4;t zu Berlin, Department of Neurology and Experimental Neurology, Berlin, Germany. fabian.boesl@charite.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goereci</LastName><ForeName>Yasemin</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Neurology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gerhard</LastName><ForeName>Ameli</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Charit&#xe9; - Universit&#xe4;tsmedizin Berlin, Corporate member of Freie Universit&#xe4;t Berlin and Humboldt-Universit&#xe4;t zu Berlin, Department of Neurology and Experimental Neurology, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bremer</LastName><ForeName>Benno</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Charit&#xe9; - Universit&#xe4;tsmedizin Berlin, Corporate member of Freie Universit&#xe4;t Berlin and Humboldt-Universit&#xe4;t zu Berlin, Department of Neurology and Experimental Neurology, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Raeder</LastName><ForeName>Vanessa</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Charit&#xe9; - Universit&#xe4;tsmedizin Berlin, Corporate member of Freie Universit&#xe4;t Berlin and Humboldt-Universit&#xe4;t zu Berlin, Department of Neurology and Experimental Neurology, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schweitzer</LastName><ForeName>Finja</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Neurology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hoppmann</LastName><ForeName>Uta</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>Experimental and Clinical Research Center, A Cooperation Between the Max Delbr&#xfc;ck Center for Molecular Medicine in the Helmholtz Association and Charit&#xe9; Universit&#xe4;tsmedizin Berlin, Berlin, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Charit&#xe9; - Universit&#xe4;tsmedizin Berlin, Corporate Member of Freie Universit&#xe4;t Berlin and Humboldt-Universit&#xe4;t zu Berlin, Experimental and Clinical Research Center, Berlin, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Max Delbr&#xfc;ck Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Behrens</LastName><ForeName>Janina</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Experimental and Clinical Research Center, A Cooperation Between the Max Delbr&#xfc;ck Center for Molecular Medicine in the Helmholtz Association and Charit&#xe9; Universit&#xe4;tsmedizin Berlin, Berlin, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Charit&#xe9; - Universit&#xe4;tsmedizin Berlin, Corporate Member of Freie Universit&#xe4;t Berlin and Humboldt-Universit&#xe4;t zu Berlin, Experimental and Clinical Research Center, Berlin, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Max Delbr&#xfc;ck Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bellmann-Strobl</LastName><ForeName>Judith</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Experimental and Clinical Research Center, A Cooperation Between the Max Delbr&#xfc;ck Center for Molecular Medicine in the Helmholtz Association and Charit&#xe9; Universit&#xe4;tsmedizin Berlin, Berlin, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Charit&#xe9; - Universit&#xe4;tsmedizin Berlin, Corporate Member of Freie Universit&#xe4;t Berlin and Humboldt-Universit&#xe4;t zu Berlin, Experimental and Clinical Research Center, Berlin, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Max Delbr&#xfc;ck Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Paul</LastName><ForeName>Friedemann</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Experimental and Clinical Research Center, A Cooperation Between the Max Delbr&#xfc;ck Center for Molecular Medicine in the Helmholtz Association and Charit&#xe9; Universit&#xe4;tsmedizin Berlin, Berlin, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Charit&#xe9; - Universit&#xe4;tsmedizin Berlin, Corporate Member of Freie Universit&#xe4;t Berlin and Humboldt-Universit&#xe4;t zu Berlin, Experimental and Clinical Research Center, Berlin, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Max Delbr&#xfc;ck Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wildemann</LastName><ForeName>Brigitte</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Molecular Neuroimmunology Group, Department of Neurology, University of Heidelberg, Heidelberg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jarius</LastName><ForeName>Sven</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Molecular Neuroimmunology Group, Department of Neurology, University of Heidelberg, Heidelberg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pr&#xfc;ss</LastName><ForeName>Harald</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Charit&#xe9; - Universit&#xe4;tsmedizin Berlin, Corporate member of Freie Universit&#xe4;t Berlin and Humboldt-Universit&#xe4;t zu Berlin, Department of Neurology and Experimental Neurology, Berlin, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>German Center for Neurodegenerative Diseases (DZNE), Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Audebert</LastName><ForeName>Heinrich J</ForeName><Initials>HJ</Initials><AffiliationInfo><Affiliation>Charit&#xe9; - Universit&#xe4;tsmedizin Berlin, Corporate member of Freie Universit&#xe4;t Berlin and Humboldt-Universit&#xe4;t zu Berlin, Department of Neurology and Experimental Neurology, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Warnke</LastName><ForeName>Clemens</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Neurology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Franke</LastName><ForeName>Christiana</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Charit&#xe9; - Universit&#xe4;tsmedizin Berlin, Corporate member of Freie Universit&#xe4;t Berlin and Humboldt-Universit&#xe4;t zu Berlin, Department of Neurology and Experimental Neurology, Berlin, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>FR 4479/1-1</GrantID><Agency>Deutsche Forschungsgemeinschaft</Agency><Country/></Grant><Grant><GrantID>PR 1274/8-1</GrantID><Agency>Deutsche Forschungsgemeinschaft</Agency><Country/></Grant><Grant><GrantID>WA 4101/2-1</GrantID><Agency>Deutsche Forschungsgemeinschaft</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>11</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>J Neurol</MedlineTA><NlmUniqueID>0423161</NlmUniqueID><ISSNLinking>0340-5354</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001323">Autoantibodies</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="Y">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001812" MajorTopicYN="N">Blood-Brain Barrier</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001323" MajorTopicYN="N">Autoantibodies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002555" MajorTopicYN="N">Cerebrospinal Fluid</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Blood&#x2013;CSF barrier dysfunction</Keyword><Keyword MajorTopicYN="N">Cerebrospinal fluid</Keyword><Keyword MajorTopicYN="N">Long-COVID</Keyword><Keyword MajorTopicYN="N">Neurology</Keyword><Keyword MajorTopicYN="N">Post-COVID</Keyword><Keyword MajorTopicYN="N">Post-acute sequelae of SARS-CoV-2 infection</Keyword></KeywordList><CoiStatement>The authors declare that they have no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>10</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>10</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>10</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>1</Month><Day>8</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>11</Month><Day>24</Day><Hour>12</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>11</Month><Day>24</Day><Hour>11</Hour><Minute>5</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>11</Month><Day>24</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37999770</ArticleId><ArticleId IdType="pmc">PMC10769962</ArticleId><ArticleId IdType="doi">10.1007/s00415-023-12092-4</ArticleId><ArticleId IdType="pii">10.1007/s00415-023-12092-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Andersson M, Alvarez-Cermeno J, Bernardi G, Cogato I, Fredman P, Frederiksen J, Fredrikson S, Gallo P, Grimaldi LM, Gronning M, et al. Cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report. J Neurol Neurosurg Psychiatry. 1994;57:897&#x2013;902. doi: 10.1136/jnnp.57.8.897.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.57.8.897</ArticleId><ArticleId IdType="pmc">PMC1073070</ArticleId><ArticleId IdType="pubmed">8057110</ArticleId></ArticleIdList></Reference><Reference><Citation>Boesl F, Audebert H, Endres M, Pruss H, Franke C. A neurological outpatient clinic for patients with post-COVID-19 syndrome&#x2014;a report on the clinical presentations of the first 100 patients. Front Neurol. 2021;12:738405. doi: 10.3389/fneur.2021.738405.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2021.738405</ArticleId><ArticleId IdType="pmc">PMC8481602</ArticleId><ArticleId IdType="pubmed">34603189</ArticleId></ArticleIdList></Reference><Reference><Citation>Brettschneider J, Claus A, Kassubek J, Tumani H. Isolated blood-cerebrospinal fluid barrier dysfunction: prevalence and associated diseases. J Neurol. 2005;252:1067&#x2013;1073. doi: 10.1007/s00415-005-0817-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-005-0817-9</ArticleId><ArticleId IdType="pubmed">15789126</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, Assaf GS, McCorkell L, Wei H, Low RJ, Re'em Y, Redfield S, Austin JP, Akrami A. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. 2021;38:101019. doi: 10.1016/j.eclinm.2021.101019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. 2023;21:133&#x2013;146. doi: 10.1038/s41579-022-00846-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Erickson MA, Rhea EM, Knopp RC, Banks WA (2021) Interactions of SARS-CoV-2 with the blood-brain barrier. Int J Mol Sci 22</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7961671</ArticleId><ArticleId IdType="pubmed">33800954</ArticleId></ArticleIdList></Reference><Reference><Citation>Franke C, Boesl F, Goereci Y, Gerhard A, Schweitzer F, Schroeder M, Foverskov-Rasmussen H, Heine J, Quitschau A, Kandil FI, Schild AK, Finke C, Audebert HJ, Endres M, Warnke C, Pruss H. Association of cerebrospinal fluid brain-binding autoantibodies with cognitive impairment in post-COVID-19 syndrome. Brain Behav Immun. 2023;109:139&#x2013;143. doi: 10.1016/j.bbi.2023.01.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2023.01.006</ArticleId><ArticleId IdType="pmc">PMC9841734</ArticleId><ArticleId IdType="pubmed">36657623</ArticleId></ArticleIdList></Reference><Reference><Citation>Galea I. The blood-brain barrier in systemic infection and inflammation. Cell Mol Immunol. 2021;18:2489&#x2013;2501. doi: 10.1038/s41423-021-00757-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41423-021-00757-x</ArticleId><ArticleId IdType="pmc">PMC8481764</ArticleId><ArticleId IdType="pubmed">34594000</ArticleId></ArticleIdList></Reference><Reference><Citation>Gold JE, Okyay RA, Licht WE, Hurley DJ (2021) Investigation of long COVID prevalence and its relationship to Epstein-Barr virus reactivation. Pathogens 10</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8233978</ArticleId><ArticleId IdType="pubmed">34204243</ArticleId></ArticleIdList></Reference><Reference><Citation>Jarius S, Pache F, Kortvelyessy P, Jelcic I, Stettner M, Franciotta D, Keller E, Neumann B, Ringelstein M, Senel M, Regeniter A, Kalantzis R, Willms JF, Berthele A, Busch M, Capobianco M, Eisele A, Reichen I, Dersch R, Rauer S, Sandner K, Ayzenberg I, Gross CC, Hegen H, Khalil M, Kleiter I, Lenhard T, Haas J, Aktas O, Angstwurm K, Kleinschnitz C, Lewerenz J, Tumani H, Paul F, Stangel M, Ruprecht K, Wildemann B, In cooperation with the German Society for Cerebrospinal Fluid D, Clinical N Cerebrospinal fluid findings in COVID-19: a multicenter study of 150 lumbar punctures in 127 patients. J Neuroinflamm. 2022;19:19. doi: 10.1186/s12974-021-02339-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-021-02339-0</ArticleId><ArticleId IdType="pmc">PMC8771621</ArticleId><ArticleId IdType="pubmed">35057809</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein J, Wood J, Jaycox J, Lu P, Dhodapkar RM, Gehlhausen JR, Tabachnikova A, Tabacof L, Malik AA, Kamath K, Greene K, Monteiro VS, Pena-Hernandez M, Mao T, Bhattacharjee B, Takahashi T, Lucas C, Silva J, McCarthy D, Breyman E, Tosto-Mancuso J, Dai Y, Perotti E, Akduman K, Tzeng TJ, Xu L, Yildirim I, Krumholz HM, Shon J, Medzhitov R, Omer SB, van Dijk D, Ring AM, Putrino D, Iwasaki A (2022) Distinguishing features of Long COVID identified through immune profiling. medRxiv</Citation></Reference><Reference><Citation>Lex A, Gehlenborg N, Strobelt H, Vuillemot R, Pfister H. UpSet: visualization of intersecting sets. IEEE Trans Vis Comput Graph. 2014;20:1983&#x2013;1992. doi: 10.1109/TVCG.2014.2346248.</Citation><ArticleIdList><ArticleId IdType="doi">10.1109/TVCG.2014.2346248</ArticleId><ArticleId IdType="pmc">PMC4720993</ArticleId><ArticleId IdType="pubmed">26356912</ArticleId></ArticleIdList></Reference><Reference><Citation>Monje M, Iwasaki A. The neurobiology of long COVID. Neuron. 2022;110:3484&#x2013;3496. doi: 10.1016/j.neuron.2022.10.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2022.10.006</ArticleId><ArticleId IdType="pmc">PMC9537254</ArticleId><ArticleId IdType="pubmed">36288726</ArticleId></ArticleIdList></Reference><Reference><Citation>Petereit H, Sindern E, Wick M (2007) CSF diagnostics. Guidelines and catalogue of methods of the German Society for cerebrospinal fluid diagnostics and clinical neurochemistry. Springer, Heidelberg</Citation></Reference><Reference><Citation>Reiber H. Cerebrospinal fluid&#x2013;physiology, analysis and interpretation of protein patterns for diagnosis of neurological diseases. Mult Scler. 1998;4:99&#x2013;107.</Citation><ArticleIdList><ArticleId IdType="pubmed">9762655</ArticleId></ArticleIdList></Reference><Reference><Citation>Reiber H. Flow rate of cerebrospinal fluid (CSF)&#x2014;a concept common to normal blood-CSF barrier function and to dysfunction in neurological diseases. J Neurol Sci. 1994;122:189&#x2013;203. doi: 10.1016/0022-510X(94)90298-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0022-510X(94)90298-4</ArticleId><ArticleId IdType="pubmed">8021703</ArticleId></ArticleIdList></Reference><Reference><Citation>Reiber H, Peter JB. Cerebrospinal fluid analysis: disease-related data patterns and evaluation programs. J Neurol Sci. 2001;184:101&#x2013;122. doi: 10.1016/S0022-510X(00)00501-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-510X(00)00501-3</ArticleId><ArticleId IdType="pubmed">11239944</ArticleId></ArticleIdList></Reference><Reference><Citation>Reiber H, Ungefehr S, Jacobi C. The intrathecal, polyspecific and oligoclonal immune response in multiple sclerosis. Mult Scler. 1998;4:111&#x2013;117. doi: 10.1177/135245859800400304.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/135245859800400304</ArticleId><ArticleId IdType="pubmed">9762657</ArticleId></ArticleIdList></Reference><Reference><Citation>Sausen DG, Bhutta MS, Gallo ES, Dahari H, Borenstein R (2021) Stress-induced Epstein-Barr virus reactivation. Biomolecules 11</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8470332</ArticleId><ArticleId IdType="pubmed">34572593</ArticleId></ArticleIdList></Reference><Reference><Citation>Schweitzer F, Goereci Y, Franke C, Silling S, Bosl F, Maier F, Heger E, Deiman B, Pruss H, Onur OA, Klein F, Fink GR, Di Cristanziano V, Warnke C. Cerebrospinal fluid analysis post-COVID-19 is not suggestive of persistent central nervous system infection. Ann Neurol. 2022;91:150&#x2013;157. doi: 10.1002/ana.26262.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.26262</ArticleId><ArticleId IdType="pmc">PMC8653324</ArticleId><ArticleId IdType="pubmed">34724243</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano JB, Murthy S, Marshall JC, Relan P, Diaz JV, Condition WHOCCDWGoP-C- A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis. 2022;22:e102&#x2013;e107. doi: 10.1016/S1473-3099(21)00703-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00703-9</ArticleId><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>St&#xf6;cker W. Autoantik&#xf6;rper gegen Myelin. In: Gressner AM, Arndt T, editors. Lexikon der Medizinischen Laboratoriumsdiagnostik. Berlin: Springer; 2019. pp. 319&#x2013;320.</Citation></Reference><Reference><Citation>Su Y, Yuan D, Chen DG, Ng RH, Wang K, Choi J, Li S, Hong S, Zhang R, Xie J, Kornilov SA, Scherler K, Pavlovitch-Bedzyk AJ, Dong S, Lausted C, Lee I, Fallen S, Dai CL, Baloni P, Smith B, Duvvuri VR, Anderson KG, Li J, Yang F, Duncombe CJ, McCulloch DJ, Rostomily C, Troisch P, Zhou J, Mackay S, DeGottardi Q, May DH, Taniguchi R, Gittelman RM, Klinger M, Snyder TM, Roper R, Wojciechowska G, Murray K, Edmark R, Evans S, Jones L, Zhou Y, Rowen L, Liu R, Chour W, Algren HA, Berrington WR, Wallick JA, Cochran RA, Micikas ME, Unit IS-SC-B, Wrin T, Petropoulos CJ, Cole HR, Fischer TD, Wei W, Hoon DSB, Price ND, Subramanian N, Hill JA, Hadlock J, Magis AT, Ribas A, Lanier LL, Boyd SD, Bluestone JA, Chu H, Hood L, Gottardo R, Greenberg PD, Davis MM, Goldman JD, Heath JR. Multiple early factors anticipate post-acute COVID-19 sequelae. Cell. 2022;185(881&#x2013;895):e820.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8786632</ArticleId><ArticleId IdType="pubmed">35216672</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, Geddes JR, Husain M, Luciano S, Harrison PJ. 6-Month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records. Lancet Psychiatry. 2021;8:416&#x2013;427. doi: 10.1016/S2215-0366(21)00084-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(21)00084-5</ArticleId><ArticleId IdType="pmc">PMC8023694</ArticleId><ArticleId IdType="pubmed">33836148</ArticleId></ArticleIdList></Reference><Reference><Citation>Tumani H, Petereit HF, Gerritzen A, Gross CC, Huss A, Isenmann S, Jesse S, Khalil M, Lewczuk P, Lewerenz J, Leypoldt F, Melzer N, Meuth SG, Otto M, Ruprecht K, Sindern E, Spreer A, Stangel M, Strik H, Uhr M, Vogelgsang J, Wandinger KP, Weber T, Wick M, Wildemann B, Wiltfang J, Woitalla D, Zerr I, Zimmermann T. S1 guidelines "lumbar puncture and cerebrospinal fluid analysis" (abridged and translated version) Neurol Res Pract. 2020;2:8. doi: 10.1186/s42466-020-0051-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s42466-020-0051-z</ArticleId><ArticleId IdType="pmc">PMC7650145</ArticleId><ArticleId IdType="pubmed">33324914</ArticleId></ArticleIdList></Reference><Reference><Citation>Tumani H PH-Fea Lumbalpunktion und Liquordiagnostik, S1-Leitlinie, 2019, in: Deutsche Gesellschaft f&#xfc;r Neurologie (Hrsg.), Leitlinien f&#xfc;r Diagnostik und Therapie in der Neurologie. Online: http://www.dgn.org/leitlinien. Accessed 21 May 2023</Citation></Reference><Reference><Citation>Vallieres L, Rivest S. Regulation of the genes encoding interleukin-6, its receptor, and gp130 in the rat brain in response to the immune activator lipopolysaccharide and the proinflammatory cytokine interleukin-1beta. J Neurochem. 1997;69:1668&#x2013;1683. doi: 10.1046/j.1471-4159.1997.69041668.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1471-4159.1997.69041668.x</ArticleId><ArticleId IdType="pubmed">9326296</ArticleId></ArticleIdList></Reference><Reference><Citation>Virhammar J, Naas A, Fallmar D, Cunningham JL, Klang A, Ashton NJ, Jackmann S, Westman G, Frithiof R, Blennow K, Zetterberg H, Kumlien E, Rostami E. Biomarkers for central nervous system injury in cerebrospinal fluid are elevated in COVID-19 and associated with neurological symptoms and disease severity. Eur J Neurol. 2021;28:3324&#x2013;3331. doi: 10.1111/ene.14703.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.14703</ArticleId><ArticleId IdType="pmc">PMC8518988</ArticleId><ArticleId IdType="pubmed">33369818</ArticleId></ArticleIdList></Reference><Reference><Citation>Wildemann B, Oschmann P, Reiber H (2010) Laboratory diagnosis in neurology. In: Wildemann B, Oschmann P, Reiber H (eds) Georg Thieme Verlag KG, Stuttgart</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>